Top 5 Largest Biotech Companies in the World

The biotechnology industry is comprised of hundreds of companies that combine biology and technology to develop medicines and related products to treat diseases and conditions. Today’s biotechnology industry includes companies that produce medical devices and diagnostics, biofuels, biomaterials, pollution controls, and more.

Look at the 5 biggest biotechnology companies in the world.

5. Argenx SE (NASDAQ:ARGX)

Market Cap: $22.02 billion

Based in the Netherlands, Argenx SE (NASDAQ:ARGX) is a major biotechnology company globally recognized for its innovative immunology solutions. Their main treatment for autoimmune diseases, efgartigimod, was created with the help of exclusive ABDEG technology and shows possibility. With a mid-2024 launch expected, Argenx SE (NASDAQ:ARGX) submitted a sBLA for VYVGART Hytrulo for CIDP to the FDA in Q1 2024, after reporting $1.2 billion in global net product sales for 2023.

4. Moderna, Inc. (NASDAQ:MRNA)

Market Cap: $39.68 billion

Moderna, Inc. (NASDAQ:MRNA) is a leading biotechnology company known for its breakthrough mRNA therapeutics and vaccines. is. Spikevax’s success during the COVID-19 pandemic highlights the company’s innovative approach to vaccine development. Moderna’s mRNA technology has great potential with applications in infectious diseases, immuno-oncology, and more. In 2023, Moderna, Inc. (NASDAQ: MRNA) reported fourth-quarter revenue of his $2.8 billion, bringing full-year revenue to his $6.8 billion. During the fall 2023 COVID-19 season, the company achieved a 48% market share in the US retail sector, demonstrating a strong market presence.

3. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Market Cap: $105.31 billion

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) was founded in Boston, MA in 1989 and is a leading company with Kalydeco, It is known for its cystic fibrosis drugs such as Orkambi and Syndeco. Trikafta/Kaftrio. It also covers infectious diseases, autoimmune diseases, cancer, and neurological diseases. Diversification includes Kasugebi for beta-thalassemia and sickle cell disease. Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) revenue for the fourth quarter of 2023 reached $154.9 million, beating estimates by $7.9 million.

2. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)

Market Cap: $105.86 billion

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is the largest developer of life-changing medicines for a variety of diseases. is one of the biotechnology companies. Founded by physicians and scientists, the company transforms discoveries into effective treatments. Regeneron has a strong pipeline and FDA-approved treatments for eye diseases, cancer, and more. Revenues in 2023 rose 8% to $13.12 billion, driven by key products such as Dupixent and EYLEA. Dupixent sales increased 33% to $11.59 billion, and EYLEA US sales reached $5.89 billion. Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)’s global net sales of Libtayo increased by 50% to $869 million.

1. Novo Nordisk A/S (NYSE:NVO)

Market Capitalization: $447.86 billion

Founded in Denmark in 1923, Novo Nordisk A/S (NYSE:NVO) is the largest biotechnology company in the world with a focus on rare diseases, diabetes, and obesity. It is well known for its cutting-edge medications, such as Wegovy, that have a major positive effect on patient outcomes in the treatment of diabetes. The goals of Novo Nordisk A/S (NYSE:NVO) are to grow into emerging therapy and cardiovascular markets. Its revenue in 2023 increased to $33.7 billion, a noteworthy 31% rise over 2022.